SGLT2 inhibitor empagliflozin could be a new treatment for children with type 2 diabetes: lancet

Published Date: 04 Mar 2023

United States: Empagliflozin could be a new treatment option for children and adolescents with type 2 diabetes, with phase 3 clinical trials showing...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The acceptance of innovative hormonal therapy for advanced prostate cancer is racialized.

2.

Disparities in use of MRI to detect prostate cancer: Race and location may influence testing

3.

For patients with prostate cancer, long-term follow-up helps identify treatment side effects.

4.

Progress in Early Cancer Diagnosis; Breast Cancer in Younger Women; Diet and Cancer.

5.

ASCO: Vepdegestrant ups survival in ER+, HER2− advanced breast cancer with ESR1 mutations


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot